Refractory and resistant hypertension: Characteristics and differences observed in a specialized clinic

Journal of the American Society of Hypertension

Volumn 9, Issue 5, 2015, Pages 397-402

  Modolo, Rodrigo ^a   De Faria, Ana Paula ^a   Sabbatini, Andréa Rodrigues ^a   Barbaro, Natália Ruggeri ^a   Ritter, Alessandra M V ^a   Moreno, Heitor ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

high blood pressure; Left ventricular hypertrophy; white coat effect

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; BIOLOGICAL MARKER;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLACK PERSON; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PATIENT IDENTIFICATION; PHENOTYPE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; ULTRASOUND TRANSDUCER; WAIST HIP RATIO; WHITE COAT HYPERTENSION; BLOOD; COMPLICATION; ECHOCARDIOGRAPHY; ETHNOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS;

EID: 84929391242     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.03.005     Document Type: Article

References (20)

1. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
2. M.C. Acelajado, R. Pisoni, T. Dudenbostel, L.J. Dell'Italia, F. Cartmill, and B. Zhang Refractory hypertension: definition, prevalence, and patient characteristics J Clin Hypertens 14 2012 7 12
3. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
4. A. de la Sierra, J.R. Banegas, A. Oliveras, M. Gorostidi, J. Segura, and J.J. de la Cruz Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs J Hypertens 30 2012 1211 1216
5. S.D. Pierdomenico, D. Lapenna, A. Bucci, R. Di Tommaso, R. Di Mascio, and B.M. Manente Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension Am J Hypertens 18 2005 1422 1428
6. D.A. Calhoun, J.N. Booth, S. Oparil, M.R. Irvin, D. Shimbo, and D.T. Lackland Refractory hypertension determination of prevalence, risk factors, and comorbidities in a large, population-based cohort Hypertension 63 2014 451 458
7. R. Modolo, A.P. de Faria, A. Almeida, and H. Moreno Resistant or refractory hypertension: are they different? Curr Hypertens Rep 16 2014 485
8. W.A. de Souza, M. Sabha, F.D. Favero, G. Bergsten-Mendes, J.C. Yugar-Toledo, and H. Moreno Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension J Clin Hypertens (Greenwich) 11 2009 183 191
9. W.A. De Souza, J.C. Yugar-Toledo, G. Bergsten-Mendes, M. Sabha, and H. Moreno Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension Am J Health Syst Pharm 64 2007 1955 1961
10. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
11. L.F. Drager, P.R. Genta, R.P. Pedrosa, F.B. Nerbass, C.C. Gonzaga, and E.M. Krieger Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension Am J Cardiol 105 2010 1135 1139
12. A. Groppelli, S. Omboni, G. Parati, and G. Mancia Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure Hypertension 20 1992 227 232
13. N.A. Zakopoulos, S.N. Nanas, J.P. Lekakis, K.N. Vemmos, V.T. Kotsis, and V.C. Pitiriga Reproducibility of ambulatory blood pressure measurements in essential hypertension Blood Press Monit 6 2001 41 45
14. D.J. Sahn, A. Demaria, J. Kisslo, and A. Weyman Recommendations regarding quantitation in m-mode echocardiography - results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. T.G. Pickering, W. Gerin, and A.R. Schwartz What is the white-coat effect and how should it be measured? Blood Press Monit 7 2002 293 300
17. P. Lantelme, H. Milon, C. Gharib, C. Gayet, and J.O. Fortrat White coat effect and reactivity to stress - cardiovascular and autonomic nervous system responses Hypertension 31 1998 1021 1029
18. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, R. D'Agostino, J.M. Flack, and B.T. Katzen A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
19. L.C. Martins, V.N. Figueiredo, T. Quinaglia, L. Boer-Martins, J.C. Yugar-Toledo, and J.F.V. Martin Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness J Hum Hypertens 25 2011 532 538
20. K.K. Gaddam, M.K. Nishizaka, M.N. Pratt-Ubunama, E. Pimenta, I. Aban, and S. Oparil Characterization of resistant hypertension - association between resistant hypertension, aldosterone, and persistent intravascular volume expansion Arch Intern Med 168 2008 1159 1164